ArticleJournal of thoracic disease2025

Predictive role of tumor-infiltrating lymphocytes and immune phenotype for pembrolizumab in relapsed or refractory thymic carcinoma.

Dong Hyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.